Brian Thomas
Fondatore presso METAGENOMI, INC.
Patrimonio netto: 17 M $ in data 30/04/2024
Profilo
Brian C.
Thomas is the founder of Metagenomi Technologies LLC and Metagenomi, Inc. which were both founded in 2016.
He held the title of Chief Executive Officer & Director at both companies.
Currently, he is the Chairman at HAYA Therapeutics SA since 2022.
Previously, he worked as a Program Manager at Berkeley University of California.
Dr. Thomas received his undergraduate and doctorate degrees from the University of Kansas.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
METAGENOMI, INC.
6.66% | 01/04/2024 | 2 496 276 ( 6.66% ) | 17 M $ | 30/04/2024 |
Posizioni attive di Brian Thomas
| Società | Posizione | Inizio |
|---|---|---|
| METAGENOMI, INC. | Fondatore | 16/09/2016 |
HAYA Therapeutics SA
 HAYA Therapeutics SA BiotechnologyHealth Technology HAYA Therapeutics SA is a Swiss precision medicines company that focuses on developing programmable therapeutics targeting regulatory RNAs derived from the dark genome to reprogram pathological cell states for a broad range of diseases, including cardiovascular disease and cancer. The company's discovery engine identifies novel targets and drug candidates with the potential for greater efficacy and safety than existing treatments. HAYA's lead therapeutic candidate is HTX-001, an antisense oligonucleotide targeting WISPER that is a heart-specific lncRNA known to be a fundamental regulator of pathological cardiac fibrosis in the context of heart failure. The company is headquartered at the Life Sciences Park Biopôle in Lausanne, CH, with laboratory facilities at JLABS @ San Diego. The company was founded by Samir Ounzain and Daniel Blessing, and Samir Ounzain has been the CEO since incorporation. | Presidente | 14/09/2022 |
Precedenti posizioni note di Brian Thomas
| Società | Posizione | Fine |
|---|---|---|
| Berkeley University of California | Corporate Officer/Principal | - |
Metagenomi Technologies LLC
 Metagenomi Technologies LLC BiotechnologyHealth Technology Metagenomi Technologies LLC engages in the development of curative therapeutics and gene-editing technologies and therapies. The company was founded by Brian C. Thomas in September 2016 and is headquartered in Emeryville, CA. | Fondatore | - |
Formazione di Brian Thomas
| University of Kansas | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| METAGENOMI, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
HAYA Therapeutics SA
HAYA Therapeutics SA BiotechnologyHealth Technology HAYA Therapeutics SA is a Swiss precision medicines company that focuses on developing programmable therapeutics targeting regulatory RNAs derived from the dark genome to reprogram pathological cell states for a broad range of diseases, including cardiovascular disease and cancer. The company's discovery engine identifies novel targets and drug candidates with the potential for greater efficacy and safety than existing treatments. HAYA's lead therapeutic candidate is HTX-001, an antisense oligonucleotide targeting WISPER that is a heart-specific lncRNA known to be a fundamental regulator of pathological cardiac fibrosis in the context of heart failure. The company is headquartered at the Life Sciences Park Biopôle in Lausanne, CH, with laboratory facilities at JLABS @ San Diego. The company was founded by Samir Ounzain and Daniel Blessing, and Samir Ounzain has been the CEO since incorporation. | Health Technology |
Metagenomi Technologies LLC
Metagenomi Technologies LLC BiotechnologyHealth Technology Metagenomi Technologies LLC engages in the development of curative therapeutics and gene-editing technologies and therapies. The company was founded by Brian C. Thomas in September 2016 and is headquartered in Emeryville, CA. | Health Technology |
- Borsa valori
- Insiders
- Brian Thomas
